Charles Schwab Investment Management Inc ENLIVEN THERAPEUTICS INC Transaction History

Charles Schwab Investment Management Inc

  • $557 Billion
  • Q2 2025
Number of Shares
305,660
Previous 259,537 17.77%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
N/A
46,123 Added 17.77%
305,660 $0
Q1 2025

May 09, 2025
SELL
N/A
-2,351 Reduced 0.9%
259,537 $0
Q4 2024

Feb 06, 2025
BUY
N/A
6,611 Added 2.59%
261,888 $0
Q3 2024

Nov 12, 2024
BUY
N/A
24,043 Added 10.4%
255,277 $0
Q2 2024

Aug 12, 2024
BUY
N/A
72,199 Added 45.4%
231,234 $0
Q1 2024

May 08, 2024
BUY
N/A
595 Added 0.38%
159,035 $0
Q4 2023

Feb 06, 2024
BUY
N/A
1,809 Added 1.15%
158,440 $0
Q3 2023

Nov 08, 2023
BUY
N/A
94,169 Added 150.76%
156,631 $0
Q2 2023

Aug 09, 2023
BUY
N/A
62,462 New
62,462 $0
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email